Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
ksbKbJNF26rJ8LFj
